Global Extracorporeal Life-support (ECLS) Blood Pump Market Growth 2026-2032
Description
The global Extracorporeal Life-support (ECLS) Blood Pump market size is predicted to grow from US$ 1889 million in 2025 to US$ 8776 million in 2032; it is expected to grow at a CAGR of 25.0% from 2026 to 2032.
The extracorporeal life support system (ECLS) and the traditional definition of extracorporeal membrane oxygenation are a modified extracorporeal circulation system used to provide long-term oxygen delivery to patients with cardiopulmonary failure. It uses an artificial extracorporeal circulation device composed of a circulating blood flow pump and an extracorporeal oxygen exchanger as the core to provide cardiopulmonary support for the purpose of extracorporeal alternative gas exchange support and heart replacement support, and provides cardiopulmonary support mainly for lung function support for patients with reversible severe cardiopulmonary dysfunction. The centrifugal pump is one of the core components of the artificial lung. The centrifugal pump artificial lung system can be regarded as a fluid control system, which is the power source part of this fluid control system, that is, the function of the heart. Its main function is to continuously extract the patient's venous blood and use centrifugal force to pump the blood into the external circulation pipeline.
At present, LVAD has gone through three rounds of iterations. The third-generation centrifugal pump technology (magnetic fluid suspension, magnetic levitation, etc.) is more excellent in performance. Since the withdrawal of Medtronic HVAD (using magnetic fluid suspension technology), full magnetic levitation (represented by Abbott HeartMate 3) has become mainstream in the United States. Clinical data show that the survival rate of full magnetic levitation LVAD is comparable to that of patients after heart transplantation, and it is expected to become the most ideal treatment method besides heart transplantation.
LP Information, Inc. (LPI) ' newest research report, the “Extracorporeal Life-support (ECLS) Blood Pump Industry Forecast” looks at past sales and reviews total world Extracorporeal Life-support (ECLS) Blood Pump sales in 2025, providing a comprehensive analysis by region and market sector of projected Extracorporeal Life-support (ECLS) Blood Pump sales for 2026 through 2032. With Extracorporeal Life-support (ECLS) Blood Pump sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Extracorporeal Life-support (ECLS) Blood Pump industry.
This Insight Report provides a comprehensive analysis of the global Extracorporeal Life-support (ECLS) Blood Pump landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Extracorporeal Life-support (ECLS) Blood Pump portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Extracorporeal Life-support (ECLS) Blood Pump market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Extracorporeal Life-support (ECLS) Blood Pump and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Extracorporeal Life-support (ECLS) Blood Pump.
This report presents a comprehensive overview, market shares, and growth opportunities of Extracorporeal Life-support (ECLS) Blood Pump market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Flows up to 10 Lpm
Flows Over 10 Lpm
Other
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Suzhou Tongxin Medical
Skynor Medical
EVAHEART
ROCOR MEDICAL Technology
magAssist
Panther
Key Questions Addressed in this Report
What is the 10-year outlook for the global Extracorporeal Life-support (ECLS) Blood Pump market?
What factors are driving Extracorporeal Life-support (ECLS) Blood Pump market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Extracorporeal Life-support (ECLS) Blood Pump market opportunities vary by end market size?
How does Extracorporeal Life-support (ECLS) Blood Pump break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The extracorporeal life support system (ECLS) and the traditional definition of extracorporeal membrane oxygenation are a modified extracorporeal circulation system used to provide long-term oxygen delivery to patients with cardiopulmonary failure. It uses an artificial extracorporeal circulation device composed of a circulating blood flow pump and an extracorporeal oxygen exchanger as the core to provide cardiopulmonary support for the purpose of extracorporeal alternative gas exchange support and heart replacement support, and provides cardiopulmonary support mainly for lung function support for patients with reversible severe cardiopulmonary dysfunction. The centrifugal pump is one of the core components of the artificial lung. The centrifugal pump artificial lung system can be regarded as a fluid control system, which is the power source part of this fluid control system, that is, the function of the heart. Its main function is to continuously extract the patient's venous blood and use centrifugal force to pump the blood into the external circulation pipeline.
At present, LVAD has gone through three rounds of iterations. The third-generation centrifugal pump technology (magnetic fluid suspension, magnetic levitation, etc.) is more excellent in performance. Since the withdrawal of Medtronic HVAD (using magnetic fluid suspension technology), full magnetic levitation (represented by Abbott HeartMate 3) has become mainstream in the United States. Clinical data show that the survival rate of full magnetic levitation LVAD is comparable to that of patients after heart transplantation, and it is expected to become the most ideal treatment method besides heart transplantation.
LP Information, Inc. (LPI) ' newest research report, the “Extracorporeal Life-support (ECLS) Blood Pump Industry Forecast” looks at past sales and reviews total world Extracorporeal Life-support (ECLS) Blood Pump sales in 2025, providing a comprehensive analysis by region and market sector of projected Extracorporeal Life-support (ECLS) Blood Pump sales for 2026 through 2032. With Extracorporeal Life-support (ECLS) Blood Pump sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Extracorporeal Life-support (ECLS) Blood Pump industry.
This Insight Report provides a comprehensive analysis of the global Extracorporeal Life-support (ECLS) Blood Pump landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Extracorporeal Life-support (ECLS) Blood Pump portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Extracorporeal Life-support (ECLS) Blood Pump market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Extracorporeal Life-support (ECLS) Blood Pump and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Extracorporeal Life-support (ECLS) Blood Pump.
This report presents a comprehensive overview, market shares, and growth opportunities of Extracorporeal Life-support (ECLS) Blood Pump market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Flows up to 10 Lpm
Flows Over 10 Lpm
Other
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Suzhou Tongxin Medical
Skynor Medical
EVAHEART
ROCOR MEDICAL Technology
magAssist
Panther
Key Questions Addressed in this Report
What is the 10-year outlook for the global Extracorporeal Life-support (ECLS) Blood Pump market?
What factors are driving Extracorporeal Life-support (ECLS) Blood Pump market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Extracorporeal Life-support (ECLS) Blood Pump market opportunities vary by end market size?
How does Extracorporeal Life-support (ECLS) Blood Pump break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
105 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Extracorporeal Life-support (ECLS) Blood Pump by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Extracorporeal Life-support (ECLS) Blood Pump by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
